| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
XMRV is a newly identified human gamma-retrovirus cloned from a prostate cancer tissue sample. Since there was no evidence to show that XMRV infection could be a possible trigger of prostate cancer generation, we assessed if XMRV-infection increased tumor malignancy. Both the anchorage dependency of tumor cells and a cell growth efficacy under lower serum concentration was not affected by XMRV infection. Then we concluded that XMRV infection did not affect a tumor malignancy. These data agreed with some other reports published from our group and others, recently.
|
